The interaction of diabetes and cancer: Recognizing the common Risk and therapeutic implications

Diabetes and cancer are two of the most common chronic illnesses in the world, and there is mounting evidence that their relationships are complicated. Liver, pancreatic, and colorectal cancer are among the cancers that people with diabetes are more likely to have. The present article examines the common risk factors that may underlie both disorders, including insulin resistance, chronic inflammation, and modified metabolic processes. Additionally, it looks at how diabetes medication impacts the course of cancer and vice versa, especially in relation to treatment results. Gaining an understanding of this interaction is essential for enhancing treatment and prevention methods as well as providing patients who have both disorders at the same time with better healthcare advice. With the potential for further study or clinical recommendations concentrating on the integrated care of people with both illnesses, this topic provides a thorough review.